Stable Isotope Labeled Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade

Reference: PX-TA1016-SIL-1MG
Product nameStable Isotope Labeled Aflibercept Biosimilar - Anti-VEGF mAb - Research Grade
SourceDrugBank DB08885
SpeciesHuman
Expression systemMammalian cells
Molecular weight115kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAflibercept
ReferencePX-TA1016-SIL
Related ProductsPX-P1167
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypehG1-Fc
ClonalityMonoclonal Antibody
SourceDrugBank DB08885
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2
Isotopic Enrichment99%
Stability1 year
FormulaC4318H6788N1164O1304S32

General information about Aflibercept

Aflibercept is a recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors fused with the Fc region of human immunoglobulin gamma 1 (IgG1). Structurally, Aflibercept is a dimeric glycoprotein with a protein molecular weight of 96.9 kilo Daltons (kDa). It contains approximately 15% glycosylation to give a total molecular weight of 115 kDa. All five putative N-glycosylation sites on each polypeptide chain predicted by the primary sequence can be occupied with carbohydrate and exhibit some degree of chain heterogeneity, including heterogeneity in terminal sialic acid residues, except at the single unsialylated site associated with the Fc domain. Aflibercept, as an ophthalmic agent, is used in the treatment of macular edema following Central Retinal Vein Occlusion (CRVO) and neovascular Age-Related Macular Degeneration (AMD). Ziv-aflibercept, under the brand name Zaltrap, was developed as an injection for treatment of metastatic colorectal cancer. This product is for research use only.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labeled Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Estrogen receptor (in E.coli)
Antigen Estrogen receptor (in E.coli) PX-P4797 108€
Glycoprotein (G) gene from patient 07-83–GA-P
Antigen Glycoprotein (G) gene from patient 07-83–GA-P PX-P4552 110€
Human EGF Recombinant Protein
Antigen Human EGF Recombinant Protein PX-P3041 135€
Human EGF Recombinant Protein
Antigen Human EGF Recombinant Protein PX-P3041 135€
Stable Isotope Labeled Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade
Biosimilar Stable Isotope Labeled Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade PX-TA1016-SIL 1500€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.